Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development

Front Physiol. 2022 May 18:13:877182. doi: 10.3389/fphys.2022.877182. eCollection 2022.

Marcela Sorelli Carneiro-Ramos¹, Gema Ruiz-Hurtado^{2

3}, Adalberto Vieyra^{4

5}

¹ Laboratory of Cardiovascular Immunology, Center of Natural and Human Sciences (CCNH), Federal University of ABC, Santo André, Brazil.
² Cardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
³ CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁴ Carlos Chagas Filho Institute of Biophysics and National Center of Structural Biology and Bioimaging/CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁵ Graduate Program in Translational Biomedicine/BIOTRANS, University of Grande Rio/UNIGRANRIO, Duque de Caxias, Brazil.

No abstract available

Keywords: cardiorenal syndrome (CRS); cardiovascular disease (7); chronic kidney disease; renal diseases; uremic compounds.

Publication types